Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021824 · ClinicalTrials.gov registry record
Severe ARDS: Generating Evidence
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 2,400
- Enrollment target
NCT03021824: Completed study, sponsored by Montefiore Medical Center.
NCT03021824 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 2,400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021824 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 2,400 participants
- Enrollment target
Study Summary
An assessment of early management of moderate-severe ARDS in the United States, including ventilator management and use of rescue therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2017-04-30 |
What the finished NCT03021824 record still lists
NCT03021824 is an observational study that tracks outcomes without assigning an intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03021824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03021824 about?
NCT03021824 is a clinical study titled "Severe ARDS: Generating Evidence". An assessment of early management of moderate-severe ARDS in the United States, including ventilator management and use of rescue therapy.
What is the current status of trial NCT03021824?
This trial is currently completed. The enrollment target is 2,400 participants. The study started on 2016-10-01. Estimated completion is 2017-04-30.
Who is sponsoring clinical trial NCT03021824?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI